Sim Mei Yi
4PUBLICATIONS
2CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (4)
Sort by Publication Date:
|Jun 08, 2019
PRL3-zumab as an immunotherapy to inhibit tumors expressing PRL3 oncoprotein.Min Thura, Abdul Qader Al-Aidaroos, Abhishek Gupta
|Jul 08, 2018
Anti-survivin effect of the small molecule inhibitor YM155 in RCC cells is mediated by time-dependent inhibition of the NF-κB pathway.Mei Yi Sim, John Shyi Peng Yuen, Mei Lin Go
|Jun 06, 2017
Action of YM155 on clear cell renal cell carcinoma does not depend on survivin expression levels.Mei Yi Sim, Hung Huynh, Mei Lin Go
Pageof 1
